Abstract 237: Preclinical evaluation of anti-HER2 Antibody Targeted Amanitin Conjugates (ATACs) on HER2low breast cancer with chromosome 17p deletion
Keyword(s):
2018 ◽
Vol 9
(4)
◽
pp. 701-714
◽
Keyword(s):
Keyword(s):
2011 ◽
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 14689-14689
◽